Dietary Sodium Restriction Impairs Insulin Sensitivity in Noninsulin-Dependent Diabetes Mellitus1
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Dietary sodium restriction has a variety of effects on metabolism, including activation of the renin-angiotensin system. Angiotensin II has complex metabolic and cardiovascular effects, and these may be relevant to the effects of both nonpharmacological and pharmacological interventions in noninsulin-dependent diabetes mellitus (NIDDM). We have assessed the effect of dietary sodium restriction on insulin sensitivity and endogenous glucose production in eight normotensive patients with diet-controlled NIDDM who underwent hyperinsulinemic clamp studies in a randomized, double-blind, placebo-controlled cross-over protocol after two 4-day periods on sodium replete (160 mmol/day) and sodium deplete (40 mmol/day) diets. Mean +/- SD 24-h urinary sodium was 197 +/- 76.0 mmol (replete) and 67 +/- 19.5 mmol (deplete), P = 0.03. Insulin sensitivity was 42.0 +/- 11.3 mumol/kg.min (replete) and 37.0 +/- 11.6 mumol/kg.min (deplete), P = 0.04 (a reduction of 12%). Blood pressure was 130 +/- 21/78 +/- 11 mmHg (replete) and 128 +/- 12/73 +/- 10 mmHg (deplete). Dietary sodium restriction may result in a decrease in peripheral insulin sensitivity in normotensive patients with NIDDM, possibly via an elevation in prevailing angiotensin II concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bergman, R. N., Prager, R., Volund, A., & Olefsky, J. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112886 · Cited by 772
Epinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 557
Liu, D., Moberg, E., Kollind, M., Lins, P. E., Adamson, U., & Macdonald, I. A. (1992) · Diabetologia · doi:10.1007/bf00400932 · Cited by 162
Research works printed but not linked: 30
- DeFronzo, 1992, Pathogenesis of NIDDM. A balanced overview., Diabetes Care, 15, 318, 10.2337/diacare.15.3.318 · DOI · Paper page
- 1996, Nutrition recommendations and principles for people with diabetes mellitus, Diabetes Care., 19, S16, 10.2337/diacare.19.1.S16 · DOI · Paper page
- 1988, Nutritional recommendations for individuals with diabetes mellitus., Diabetes Nutr Metab, 1, 145
- Pollare, 1989, A comparison of the effects of hydrochlorthiazide and captopril on glucose and lipid metabolism in patients with hypertension., N Engl J Med, 321, 868, 10.1056/NEJM198909283211305 · DOI · Paper page
- Rett, 1986, 62, 59
- Vuorinen-Markkola, 1995, Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus., Metabolism, 44, 85, 10.1016/0026-0495(95)90293-7 · DOI
- Buchanan, 1993, Angiotensin II increases glucose utilization during acute hyperinsulinaemia via a hemodynamic mechanism., J Clin Invest, 92, 720, 10.1172/JCI116642 · DOI · Paper page
- Widgren, 1993, Low dose angiotensin II increases glucose disposal rate during euglycaemic hyperinsulinaemia., Am J Hypertens, 6, 892, 10.1093/ajh/6.10.892 · DOI
- Fliser, 1997, Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset., J Hypertens, 15, 293, 10.1097/00004872-199715030-00011 · DOI
- Morris, 1994, Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM., Diabetes, 43, 1445, 10.2337/diab.43.12.1445 · DOI
- Sharma, 1993, Insulin resistance in young salt sensitive subjects., Hypertension, 21, 273, 10.1161/01.HYP.21.3.273 · DOI · Paper page
- Donovan, 1993, Effect of sodium intake on insulin sensitivity, Am J Physiol., 264, E730
- Fliser, 1995, The effect of dietary salt on insulin sensitivity., Eur J Clin Invest, 25, 39, 10.1111/j.1365-2362.1995.tb01523.x · DOI · Paper page
- Grey, 1996, Moderate dietary salt restriction does not alter insulin resistance or serum lipids in normal men., Am J Hypertens, 9, 317, 10.1016/0895-7061(95)00390-8 · DOI · Paper page
- McFadyen, 1993, Haemodynamic and hormonal responses to oral enalapril in salt-depleted normotensive man., Br J Clin Pharmacol, 35, 299, 10.1111/j.1365-2125.1993.tb05697.x · doi:10.1111/j.1365-2125.1993.tb05697.x
- DeFronzo, 1979, Glucose clamp technique: a method for quantifying insulin secretion and resistance, Am J Physiol., 237, E214
- Hother-Nielsen, 1990, On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed continuous 3-3H glucose infusion., Diabetologia, 33, 603, 10.1007/BF00400204 · DOI
- 1945, Determination of blood sugar., J Biol Chem, 160, 69, 10.1016/S0021-9258(18)43098-0 · DOI · Paper page
- Morton, 1985, Measurement of plasma angiotensin II., Clin Sci, 68, 483, 10.1042/cs0680483 · DOI
- Steele, 1956, Measurement of size and turnover rate of body glucose pool by the isotope dilution method., Am J Physiol, 187, 15, 10.1152/ajplegacy.1956.187.1.15 · DOI · Paper page
- DeBodo, 1963, On the hormonal regulation of carbohydrate metabolism: studies with C14 glucose., Recent Prog Horm Res, 19, 445
- DeWitt, 1983, Stimulation of glycogenolysis in hepatocytes by angiotensin II may involve both calcium release and calcium influx., FEBS Lett, 160, 259, 10.1016/0014-5793(83)80978-8 · DOI
- Kneer, 1983, Regulation of gluconeogenesis by norepinephrine, vasopressin and angiotensin II: a comparative study in the absence and presence of extracellular calcium., Arch Biochem Biophys, 225, 187, 10.1016/0003-9861(83)90022-X · DOI
- Taddei, 1995, Angiotensin II and sympathetic nervous system activity in sodium-restricted essential hypertension., Hypertension, 25, 595, 10.1161/01.HYP.25.4.595 · doi:10.1161/01.hyp.25.4.595
- Morris, 1996, Angiotensin II: an insulin-sensitising vasoactive hormone?, J Clin Endocrinol Metab, 81, 1303, 10.1210/jcem.81.4.8636320 · doi:10.1210/jcem.81.4.8636320 · Paper page
- Smrcka, 1991, Regulation of polyphoinositide specific phospholipase C activity by purified Gq., Science, 251, 804, 10.1126/science.1846707 · DOI · Paper page
- Velloso, 1996, Cross-talk between the insulin and angiotensin signalling systems., Proc Natl Acad Sci USA, 93, 12490, 10.1073/pnas.93.22.12490 · DOI · Paper page
- Hollenberg, 1974, Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man., J Clin Invest, 54, 34, 10.1172/JCI107748 · DOI · Paper page
- Rocchini, 1990, Hyperinsulinaemia and the aldosterone and pressor responses to angiotensin II., Hypertension, 15, 861, 10.1161/01.HYP.15.6.861 · DOI
- Dawson-Hughes, 1981, Plasma angiotensin II concentration regulates vascular but not adrenal responsiveness to restriction of sodium intake in normal man., Clin Sci, 61, 527, 10.1042/cs0610527 · doi:10.1042/cs0610527
Cited by
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373
Effect of longer-term modest salt reduction on blood pressure
He, F. J., Li, J., & MacGregor, G. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004937.pub2 · Cited by 722
Sodium Intake and Hypertension
Grillo, A., Salvi, L., Coruzzi, P., Salvi, P., & Parati, G. (2019) · Nutrients · doi:10.3390/nu11091970 · Cited by 701
Metadata
- Authors
- Petrie, J. R., Morris, A. D., Minamisawa, K., Hilditch, T. E., Elliott, H. L., Small, M., & MC Connell, J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-05-01
- Volume
- 83
- Issue
- 5
- Pages
- 1552-1557
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2136808820
- Cited by
- 59
- References
- 3
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.